Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eculizumab in Adult Patients With Atypical Hemolytic-uremic Syndrome
NCT01194973Phase 2Completed
- Sponsor
- Alexion Pharmaceuticals
- Start
- Jul 2010
- Primary completion
- Oct 2013
- Modality
- Recombinant Proteins and Enzymes, Monoclonal Antibodies
- Countries
- 7
01
Overview
A Phase 2 trial of eculizumab in atypical hemolytic uremic syndrome (aHUS), sponsored by Alexion Pharmaceuticals. Started Jul 2010; status: completed.
02
Drugs
eculizumab
03
Conditions
atypical hemolytic uremic syndrome (aHUS)
Beyond the preview
Go deeper on NCT01194973.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01194973.